LYSOPAÏNE MAUX DE GORGE AMBROXOL MENTHE 17.86 mg/ml sugar-free, solution as an oromucosal spray sweetened with sucralose bottle, 20 ml
Active ingredients: Ambroxol hydrochloride
Commercialized according to BDPM
Solution for sprayingbottle, 20 mlvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LYSOPAÏNE MAUX DE GORGE AMBROXOL MENTHE 17,86 mg/ml SANS SUCRE, solution pour pulvérisation buccale édulcorée au sucralose
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- voie buccale autre
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 20 ml avec pompe(s) doseuse(s) avec embout(s) buccal(aux) matière plastique
- Marketing authorisation holder
- OPELLA HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Dec 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62239384CIP73001108CIP133400930011089Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AMBROXOLsolution | 17,86 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.